Immunohistochemical localization of glutathione peroxidase 1 enzyme and its gene expression by RT-PCR in the liver tissue of healthy and diabetic mice
The purpose of this study is to examine the gene expression level of glutathione peroxidase 1 (GPx1) in the liver of healthy and diabetic mice, its localization in the tissue, and structural changes in the liver. In this study, 36 Swiss albino mice were divided into 3 groups: experimental (diabetic) (n = 15), sham (n = 15), and control (n = 6). Streptozotocin (100 mg/kg) was intraperitoneally administered to mice in the experimental group. While the gene expression level of GPx1 was determined using the RT-PCR method, its localization in the liver was determined using an immunohistochemical method. The GPx1 enzyme activity of the experimental group was lower compared to the sham and control groups (P < 0.05). There was no difference between the experimental and sham groups in terms of the gene expression of GPx1; however, a statistically insignificant decrease was observed in the experimental group compared to the sham group. GPx1 had similar immunolocalization in all groups, but GPx1 immunoreactivity was lower in the experimental group compared to the other groups. Enlargement of hepatocytes and their nuclei as well as the presence of intranuclear inclusion bodies were observed in the experimental group. In conclusion, diabetes mellitus causes a decrease in the level of GPx1 activity, which is known to be one of the antioxidant enzymes.
Immunohistochemical localization of glutathione peroxidase 1 enzyme and its gene expression by RT-PCR in the liver tissue of healthy and diabetic mice
The purpose of this study is to examine the gene expression level of glutathione peroxidase 1 (GPx1) in the liver of healthy and diabetic mice, its localization in the tissue, and structural changes in the liver. In this study, 36 Swiss albino mice were divided into 3 groups: experimental (diabetic) (n = 15), sham (n = 15), and control (n = 6). Streptozotocin (100 mg/kg) was intraperitoneally administered to mice in the experimental group. While the gene expression level of GPx1 was determined using the RT-PCR method, its localization in the liver was determined using an immunohistochemical method. The GPx1 enzyme activity of the experimental group was lower compared to the sham and control groups (P < 0.05). There was no difference between the experimental and sham groups in terms of the gene expression of GPx1; however, a statistically insignificant decrease was observed in the experimental group compared to the sham group. GPx1 had similar immunolocalization in all groups, but GPx1 immunoreactivity was lower in the experimental group compared to the other groups. Enlargement of hepatocytes and their nuclei as well as the presence of intranuclear inclusion bodies were observed in the experimental group. In conclusion, diabetes mellitus causes a decrease in the level of GPx1 activity, which is known to be one of the antioxidant enzymes.
___
- Czuczejko J, Zachara BA, Staubach-Topczewska E, Halota W,
- Kedziora J. Selenium, glutathione and glutathione peroxidases
- in blood of patients with chronic liver diseases. Acta Biochim
- Pol 2003; 50: 1147–1154. 5.
- Stadtman TC. Biological function of selenium. Nutr Rev 1977; 35: 161–166. 6.
- Sanai T, Sobka T, Johnson T, el-Essawy M, Muchaneta-Kubara
- EC, Ben Gharbia O, el Oldroyd S, Nahas AM. Expression
- of cytoskeletal proteins during the course of experimental
- Matkovics B, Szabo L, Varga I. Determination of enzyme
- activities in lipid peroxidation and glutathione pathways. Lab Diag 1988; 15: 248–250.
- Chomczynski P, Sacchi N. Single-step method of RNA
- isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159.
- Ferret PJ, Soum E, Negre O, Fradelizi D. Auto-protective redox
- buffering systems in stimulated macrophages. BMC Immunol 2002; 12: 3.
- Kocamış H. Functional profiles of growth related genes
- during embryogenesis and postnatal development of chicken and mouse skeletal muscle. PhD, West Virginia University, Morgantown, WV, USA, 2001.
- Doi K, Yamanouchi J, Kume E, Yasoshima A. Morphologic
- changes in hepatocyte nuclei of streptozotocin (SZ)-induced diabetic mice. Exp Toxicol Pathol 1997; 49: 295–299.
- Fujita A, Sasaki H, Ogawa K, Okamoto K, Matsuno S,
- Matsumoto E, Furuta H, Nishi M, Nakao T, Tsuno T et al. Increased gene expression of antioxidant enzymes in KKAy diabetic mice but not in STZ diabetic mice. Diabetes Res Clin Pract 2005; 69: 113–119.
- Imaeda A, Kaneko T, Aoki T, Kondo Y, Nagase H. DNA damage
- and the effect of antioxidants in streptozotocin-treated mice. Food Chem Toxicol 2002; 40: 979–987.
- Watkins JB 3rd, Gardner PA, Feczko JD, Klueber KM.
- Streptozotocin and insulin-dependent diabetes induce changes in hepatic cytoarchitecture in mice. Int J Toxicol 2000; 19: 401– 405.
- Noorafshan A, Esmail-Zadeh B, Bahmanpour S, Poost-Pasand
- A. Early stereological changes in liver of Sprague-Dawley rats after streptozotocin injection. Indian J Gastroenterol 2005; 24: 104–107.
- Cho SY, Park JY, Park EM, Choi MS, Lee MK, Jeon SM, Jang
- MK, Kim MJ, Park YB. Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract. Clin Chim Acta 2002; 317: 109–117.
- Garg MC, Bansal DD. Protective antioxidant effect of vitamins
- C and E in streptozotocin induced diabetic rats. Indian J Exp Biol 2000; 38: 101–104.
- Can B, Ulusu NN, Kilinç K, Acan NL, Saran Y, Turan B.
- Selenium treatment protects diabetes-induced biochemical and ultrastructural alterations in liver tissue. Biol Trace Elem Res 2005; 105: 135–150.
- Kinalski M, Sledziewski A, Telejko B, Zarzycki W, Kinalska
- I. Lipid peroxidation and scavenging enzyme activity in streptozotocin-induced diabetes. Acta Diabetol 2000; 37: 179– 183.
- Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J.
- Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163–176.
- Otsuka Y, Ueta E, Yamamoto T, Tadokoro Y, Suzuki E, Nanba
- E, Kurata T. Effect of streptozotocin-induced diabetes on rat liver mRNA level of antioxidant enzymes. Int Cong Ser 2002; 1245: 421–423.
- Laguens RP, Candela S, Hernández RE, Gagliardino JJ.
- Streptozotocin-induced liver damage in mice. Horm Metab Res 1980; 12: 197–201.
- Honjo K, Doi K, Doi C, Mitsuoka T. Histopathology of
- streptozotocin-induced diabetic DBA/2N and CD-1 mice. Lab Anim 1986; 20: 298–303.
- Yoshimura S, Komatsu N, Watanabe K. Purification and
- immunohistochemical localization of rat liver glutathione peroxidase. Biochem Biophsy Acta 1980; 621: 130–137.
- Asayama K, Yokota S, Dobashi K, Hayashibe H, Kawaoi A,
- Nakazawa S. Purification and immunoelectron microscopic localization of cellular glutathione peroxidase in rat hepatocytes: quantitative analysis by postembedding method. Histochemistry 1994; 102: 213–219.
- Asayama K, Dobashi K, Kawada Y, Nakane T, Kawaoi
- A, Nakazawa S. Immunohistochemical localization and quantitative analysis of cellular glutathione peroxidase in foetal and neonatal rat tissues: fluorescence microscopy image analysis. Histochem J 1996; 28: 63–71.
- Utsunomiya H, Komatsu N, Yoshimura S, Tsutsumi Y,
- Watanabe K. Exact ultrastructural localization of glutathione peroxidase in normal rat hepatocytes: advantages of microwave fixation. J Histochem Cytochem 1991; 39: 1167–1174.